DE2723468A1 - Neue pyrazinderivate und verfahren zu deren herstellung - Google Patents
Neue pyrazinderivate und verfahren zu deren herstellungInfo
- Publication number
- DE2723468A1 DE2723468A1 DE19772723468 DE2723468A DE2723468A1 DE 2723468 A1 DE2723468 A1 DE 2723468A1 DE 19772723468 DE19772723468 DE 19772723468 DE 2723468 A DE2723468 A DE 2723468A DE 2723468 A1 DE2723468 A1 DE 2723468A1
- Authority
- DE
- Germany
- Prior art keywords
- methoxy
- dimethylergoline
- methyl
- amino
- chloropyrazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims description 11
- 238000004519 manufacturing process Methods 0.000 title description 3
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical class C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 12
- 239000000460 chlorine Substances 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 3
- AEVSSZHXGJAPIE-UHFFFAOYSA-N 3-chloropyrazin-2-amine Chemical compound NC1=NC=CN=C1Cl AEVSSZHXGJAPIE-UHFFFAOYSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 150000003216 pyrazines Chemical class 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004623 platelet-rich plasma Anatomy 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- LVXVIPZBNJSUKL-NJAPINKUSA-N [(6ar,9r,10as)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6h-indolo[4,3-fg]quinoline-9-yl]methanol Chemical compound C1=CC([C@]2(OC)[C@H](N(C)C[C@H](CO)C2)C2)=C3C2=CN(C)C3=C1 LVXVIPZBNJSUKL-NJAPINKUSA-N 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- HKAVADYDPYUPRD-UHFFFAOYSA-N 1h-pyrazine-2-thione Chemical compound SC1=CN=CC=N1 HKAVADYDPYUPRD-UHFFFAOYSA-N 0.000 description 1
- JTPXVCKCLBROOJ-UHFFFAOYSA-N 2-amino-6-chloropyrazine Chemical compound NC1=CN=CC(Cl)=N1 JTPXVCKCLBROOJ-UHFFFAOYSA-N 0.000 description 1
- ABQYSTWSLKDOGY-UHFFFAOYSA-N 3-chloro-1h-pyrazine-2-thione Chemical compound SC1=NC=CN=C1Cl ABQYSTWSLKDOGY-UHFFFAOYSA-N 0.000 description 1
- JWJMFXANLBMUDY-UHFFFAOYSA-N 3-methoxy-1h-pyrazine-2-thione Chemical compound COC1=NC=CN=C1S JWJMFXANLBMUDY-UHFFFAOYSA-N 0.000 description 1
- MTMGQKFGZHMTTK-UHFFFAOYSA-N 3-methoxypyrazin-2-amine Chemical compound COC1=NC=CN=C1N MTMGQKFGZHMTTK-UHFFFAOYSA-N 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 101100533558 Mus musculus Sipa1 gene Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- XMVAISYXWMEOTD-MQVPCNEGSA-N [(6ar,9r,10as)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6h-indolo[4,3-fg]quinoline-9-yl]methyl 4-methylbenzenesulfonate Chemical compound C([C@@H]1C[C@]2([C@H](N(C)C1)CC=1C3=C2C=CC=C3N(C)C=1)OC)OS(=O)(=O)C1=CC=C(C)C=C1 XMVAISYXWMEOTD-MQVPCNEGSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- WPUJEWVVTKLMQI-UHFFFAOYSA-N benzene;ethoxyethane Chemical compound CCOCC.C1=CC=CC=C1 WPUJEWVVTKLMQI-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- XFTQRUTUGRCSGO-UHFFFAOYSA-N pyrazin-2-amine Chemical compound NC1=CN=CC=N1 XFTQRUTUGRCSGO-UHFFFAOYSA-N 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB21801/76A GB1549829A (en) | 1976-05-26 | 1976-05-26 | 10'-methoxy-1',6'-dimethylergoline-8'-beta-methyl-amino(or thio)-pyrazines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2723468A1 true DE2723468A1 (de) | 1977-12-15 |
Family
ID=10169044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19772723468 Withdrawn DE2723468A1 (de) | 1976-05-26 | 1977-05-24 | Neue pyrazinderivate und verfahren zu deren herstellung |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4123613A (enExample) |
| JP (1) | JPS52144698A (enExample) |
| CH (1) | CH630918A5 (enExample) |
| DE (1) | DE2723468A1 (enExample) |
| FR (1) | FR2352815A1 (enExample) |
| GB (1) | GB1549829A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT382374B (de) * | 1981-11-04 | 1987-02-25 | Sandoz Ag | Verfahren zur herstellung von neuen n-substituierten ergolin- und 9,10-didehydroergolin-8-carboxamid-derivaten |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3705060C1 (de) * | 1987-02-18 | 1988-03-03 | Alfmeier Walter Gmbh & Co | Unterdruckverteilerdose |
| KR0138005B1 (ko) * | 1993-10-21 | 1998-05-15 | 김낙두 | 신규의 화학적 보호제(chemopreventive agent)및 그의 제조방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3238211A (en) * | 1966-03-01 | Derhvatives of g-methyl and i,g-dimethyl ergolhne | ||
| US3996228A (en) * | 1973-12-21 | 1976-12-07 | Societa' Farmaceutici Italia S.P.A. | Pyrimidinoaminoethyl ergoline derivatives |
| US4004011A (en) * | 1974-04-16 | 1977-01-18 | Sandoz Ltd. | 3-Pyridylamine substituted ergolines |
| US3901894A (en) * | 1974-06-06 | 1975-08-26 | Lilly Co Eli | 8-thiomethylergolines |
-
1976
- 1976-05-26 GB GB21801/76A patent/GB1549829A/en not_active Expired
-
1977
- 1977-05-23 FR FR7715719A patent/FR2352815A1/fr active Granted
- 1977-05-23 US US05/799,167 patent/US4123613A/en not_active Expired - Lifetime
- 1977-05-24 JP JP6038377A patent/JPS52144698A/ja active Pending
- 1977-05-24 CH CH640177A patent/CH630918A5/de not_active IP Right Cessation
- 1977-05-24 DE DE19772723468 patent/DE2723468A1/de not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT382374B (de) * | 1981-11-04 | 1987-02-25 | Sandoz Ag | Verfahren zur herstellung von neuen n-substituierten ergolin- und 9,10-didehydroergolin-8-carboxamid-derivaten |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS52144698A (en) | 1977-12-02 |
| US4123613A (en) | 1978-10-31 |
| FR2352815A1 (fr) | 1977-12-23 |
| GB1549829A (en) | 1979-08-08 |
| CH630918A5 (de) | 1982-07-15 |
| FR2352815B1 (enExample) | 1980-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3529529C2 (enExample) | ||
| DE3002761C2 (de) | Secalonsäuren mit 2,4'-Bindung und 4,4'-Bindung, Verfahren zu deren Herstellung und deren Verwendung bei der Bekämpfung bakterieller Infektionen | |
| DE2446758C3 (de) | 2-(2-Fluor-6-trifluormethylphenylimino)-imidazolidin, dessen Säureadditionssalze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung der Hypertonie | |
| DE2723468A1 (de) | Neue pyrazinderivate und verfahren zu deren herstellung | |
| CH659713A5 (de) | Spezifisches bindungs-testverfahren und reagenszusammensetzung zur durchfuehrung dieses verfahrens. | |
| DE3512629C2 (de) | s-Triazolo[1,5-a]pyrimidine und Verfahren zu ihrer Herstellung | |
| DE2418432A1 (de) | Tricyclische arylalkylenlactamimide, verfahren zu deren herstellung und deren verwendung | |
| DE69124699T2 (de) | Neues salicylsäure-maltol-konjugat | |
| DE2524284A1 (de) | Adenosin-derivate und verfahren zu ihrer herstellung | |
| DE2432702A1 (de) | Verfahren zur herstellung von hydroxyalkylxanthinen | |
| CH622018A5 (en) | Process for the preparation of novel monoalkenyldialkylxanthines | |
| CH627466A5 (de) | Verfahren zur herstellung von heterocyclischen ergolinderivaten. | |
| AT336182B (de) | Verfahren zur herstellung eines prothrombinkomplexes | |
| DE1902651C3 (de) | Neue Kortikoid-21-monophosphate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| DE1927802C2 (de) | DHO-Prostadiensäure sowie diese enthaltende pharmazeutische Präparate | |
| DE2318043C3 (de) | Bis-eckige Klammer auf 4,7-dihydroxycumarinyl-(3) eckige Klammer zu- essigsäure und deren pharmakologisch verträgliche Salze sowie Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE1011888B (de) | Verfahren zur Herstellung von Theophyllinderivaten | |
| AT209007B (de) | Verfahren zur Herstellung von 9 α-Halogen-4-pregnen-16 α, 17 α,21-triol-3, 11, 20-trionen und ihren Estern | |
| DE1918794A1 (de) | Verfahren zur Herstellung bisher unbekannter Derivate eines Antibioticums | |
| DE1795827A1 (de) | Adenosinderivate und verfahren zu ihrer herstellung | |
| DE1963597C3 (de) | Neue Neriifolin-Derivate, Verfahren zur Herstellung derselben sowie diese enthaltende Arzneimittel | |
| EP0040685A2 (de) | Lysergsäurederivate und deren pharmazeutische Zubereitungen | |
| AT235475B (de) | Verfahren zur Herstellung neuer, wasserlöslicher, therapeutisch verwendbarer Salze des Hydrocortisons | |
| DE1670076A1 (de) | Verfahren zur Herstellung der exo-Form des 2',3'-O-Benzylidenadenosins | |
| AT227703B (de) | Verfahren zur Herstellung einer neuen Sulfonamido-Verbindung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8139 | Disposal/non-payment of the annual fee |